Medicus Sciences Acquisition in an 8-K filing said it received a Nasdaq notice that it faces delisting for failure to hold an annual meeting of shareholders within the required timeline.
Because it is unlikely Medicus will be able to complete a business combination before its Feb. 18 completion deadline, SPAC in the filing said it intends to liquidate after the deadline.
The SPAC raised $92 million in a February 2021 ipo to focus on the medical technology sector, both in the United States and internationally.
Medicus almost a year ago called off merger talks with Anteris Technology, an Australia-based medical tech company focused on structural heart components, including heart valves. Read more.
Source: Medicus Sciences Acquisition Warned of Nasdaq Delisting, Opts to Liquidate